Advances in Psoriasis Treatment: Emerging Therapies and Future Directions
The psoriasis research pipeline is rich with new medications as well as new ways to use existing therapies, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Fernandez, who outlined three therapeutic areas he’s most excited about in the treatment of p …
The psoriasis research pipeline is rich with new medications as well as new ways to use existing therapies, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Fernandez, who outlined three therapeutic areas he’s most excited about in the treatment of p … Continue reading "Advances in Psoriasis Treatment: Emerging Therapies and Future Directions"
Derm residents, exciting news! The ODAC Dermatology Conference Board Review Workshop Sessions are now live on the Dermatology In-Review website.
If you’re deep in the trenches studying for the upcoming board exams, you know just how valuable these sessions can be. Curated by experts and tailored to align with the high-yield topics you need to know, these workshops are an incredible resource t … 
At the 2025 ODAC Dermatology Conference, Dr. C. William Hanke, MD, MPH, Professor of Dermatology, Marian University COM in Indianapolis, and triple board-certified in Dermatology, Pathology, and Micrographic Dermatologic Surgery, presented on procedural treatments for preventing nonmelanoma skin cancer (NMSC). His lecture highlighted innovative approaches to reducing this risk through various cosm … 
At the 2025 ODAC Dermatology Conference, expert dermatologist Anthony Fernandez, MD, PhD presented a masterful talk on Advances in Psoriasis Treatment: Emerging Therapies and Future Directions. He explored emerging therapies and future directions in psoriasis management. Since 2004, the FDA has approved 14 novel systemic agents to treat moderate to severe psoriasis, 12 of which are biologics, an … 
At the 2025 ODAC Dermatology conference, Dr. Anthony Fernandez, MD, PhD gave an informative presentation titled, No-Brainer Approaches to Neutrophilic Dermatoses. His presentation focused on discussing the clinical presentation, differential diagnosis considerations, and treatment options of pyoderma gangrenosum and Sweet syndrome.
Pyoderma Gangrenosum (PG)
Pyoderma gangrenosum typically present …